Your Article Summary
See Latest ArticlesFIGO stage IIIC endometrial carcinoma: Prognostic factors and outcomes
Gynecologic Oncology, 07/01/09
Hoekstra AV et al. - Endometrial cancer patients with FIGO stage IIIC had a 5-year OS of 61.3%, a RFS of 58.0% and a DSS of 71.9% in this series. Because of the high proportion of distant sites of recurrence (71.4%), recurrence outside the radiation field (100%), and mortality after recurrence (86.3%), multimodality therapy should be considered.
Related Articles
Local Biosynthesis of Estrogen in Human Endometrial Carcinoma through Tumor-Stromal Cell Interactions
Clinical Cancer Research, 10/06/09
Relevance Score: 70%
Endometrial Cancer
American Family Physician, 11/12/09
Relevance Score: 68%
p53 overexpression in morphologically ambiguous endometrial carcinomas correlates with adverse clinical outcomes
Modern Pathology, 10/28/09
Relevance Score: 68%
Prognostic markers for coexistent carcinoma in high-risk endometrial hyperplasia with negative D-score: significance of morphometry, hormone receptors and apoptosis for outcome prediction
Acta Obstetricia et Gynecologica Scandinavica, 10/09/09
Relevance Score: 67%
Deoxyribonucleic acid ploidy in endometrial carcinoma: a reproducible and valid prognostic marker in a routine diagnostic setting
American Journal of Obstetrics and Gynecology, 10/08/09
Relevance Score: 67%
Today in Gynecologic Oncology...keeping you current
Receive free subspecialty "5-minute updates" via email
Recreational physical activity and risk of epithelial ovarian cancer
Cancer Causes and Control, 12/14/09
The role of hyperthermic intraoperative intraperitoneal chemotherapy (HIPEC) in the treatment of peritoneal carcinomatosis in recurrent ovarian cancer
Clinical and Translational Oncology, 12/14/09
Gonadotropin and steroid receptors as prognostic factors in advanced ovarian cancer: a retrospective study
Clinical and Translational Oncology, 12/14/09